(R,S)-4-Fmoc-3-carboxymethyl-piperazin-2-one, 98.0%, 250mg

2,4-Dimethylpyrimidin-5-ol, 95.0%, 1g

2-Chloro-N-(cyclohex-1-en-1-yl)-N-(furan-2-ylmethyl)acetamide, 97%, 250mg

Benzo[h]quinoline, 98.0%, 1g

6-chloro-3-methyl-1H-pyrrolo[3,2-b]pyridine, 100mg

(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, 98%, 100mg

(Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulfonate, 95.0%, 5g

3,3-DIFLUOROPIPERIDINE-4,4-DIOL HCL, 95.0%, 1g

ETHYL 1-CYCLOPROPYL-6,7-DIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE, 97.0%, 25g

1-(3-Fluoro-5-(trifluoromethyl)pyridin-2-yl)ethanol, 95.0%, 100mg

7-OXA-4-AZASPIRO[2.5]OCTANE, 95%, 250mg

Transition piece NS-KS Ground joint cone on spherical joint connection, 35, 1 Piece

5,5'-Bis(trimethylstannyl)-2,2'-bithiophene, 97.0%, 5g